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Abstract
In recent years, a growing concern in the medical field has been the ability to treat
infectious diseases. The microorganisms that cause these diseases have developed invasive
mechanisms that elude possible treatments and increase their virulence. Some virulent
factors that have been observed in microorganisms are biofilm and endospore formation.
Development of new antimicrobial agents are needed to combat these microorganisms.
Green tea from the leaves of Camellia sinensis, has many health benefits, such as
anti-bacterial, anti-spore, anti-cariogenic and anti-viral properties. Epigallocatechin-3gallate (EGCG) is the most abundant catechin and contributes to these effects. Due to the
instability of EGCG, a modified stable lipophilic based molecule Epigallocatechin GallateStearate (EGCG-S) was used to determine the effectiveness as an antimicrobial agent on
eight gram-positive bacteria, seven gram-negative bacteria, one acid-fast bacterium, one
fungus. Colony forming unit (CFU) was used to determine the growth. LIVE/DEAD®
BaclightTM Kit was used to observe the viability of the cells; Congo red assay was used to
study the biofilm formation and Rapid Agar Plate Assay (RAPA) was used to study the
application of EGCG-S as an antimicrobial agent. The results indicated that the minimum
inhibitory concentration (MIC) for most bacteria is 250μg/mL of EGCG-S within 2 hours,
except K. pneumoniae and M. smegmatis. MIC for biofilm formation is 500μg/ml EGCGS for most bacteria. One percent (1%) and 5% sucrose concentrations can reduce the
inhibitory effect of EGCG-S. Formulated prototype, ProtecTeaV is effective in treating C.
albicans and three endospore forming Bacillus spp. Percentage of inhibition was above
95.97 within 60 seconds. This study suggested that EGCG-S can be a good potential
antimicrobial agent.
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Introduction
Since the 19th century, microorganisms have been identified as the causative agent
of many diseases such as tuberculosis caused by Mycobacterium tuberculosis, cholera
caused by Vibrio cholerae, and Candida albicans causing thrush of the oral and vaginal
cavity (Aminov, 2010; Kadosh & Johnson, 2005; Lederberg, 2000). Penicillin was
discovered in 1928 by Alexander Fleming and was seen as a breakthrough in treating
bacterial infections (Aminov, 2010). Therapeutic agent, fluconazole was formulated and
treats fungal infections (Kartsonis et al., 2003). Due to the excessive misuse of
antimicrobial agents, microorganisms have begun to display resistance to certain
antimicrobial agents (Aminov, 2010; CDC, 2015: Cohen, 1992). Antimicrobial resistance
has been observed in penicillinase-producing Staphylococcus aureus and antifungal
resistance to fluconazole has been observed in Candida albicans (Aminov, 2010; CDC,
2015; Hirasawa & Takada, 2004; Saga et al., 2009). Resistance to these antimicrobial
agents has been attributed to a variety of mechanisms: antimicrobial selective pressures,
incorporation of plasmid, and efflux pumps (Cohen, 1992; Davin-Regli & Pagès, 2015;
Hirasawa & Takada, 2004; Zhang et al., 2015).

Pathogenesis and the invasive mechanisms
The prevalence of infections has decreased since the introduction of antimicrobial
agents; however, microorganisms have developed and acquired virulent mechanisms that
enable them to elude detection from the host immune system (Rohmer et al., 2011, Saga et
al., 2009, Vila et al., 2017). This allows their survival and establishes a niche that causes
persistent infections. Virulent factors are a growing concern in the medical field and have
been associated with persistent bacterial and fungal infections, bacterial biofilm formation,
and endospore formation. Bacteria have evolved and acquired genes that are used to
establish the foundation biofilm formation that antibiotics are unable to penetrate (Donlan
& Costerton, 2002; Meh & O’Toole, 2001). The virulence of C. albicans is established
through the filamentous activity, which enhances size of the organism without replication
(Vila et al., 2017). This activity has been a focus for development of new antifungal agents.
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The vegetative cells of Bacillus and Clostridium spp. form endospores in hostile
environments when nutrients are limited and sporulation begins (Drobniewski, 1993).

Biofilm Formation
Biofilms are aggregations of microorganism that adhere to one another and
surfaces. The biofilm provides structure and protection from the environment (Donlan &
Costerton, 2002; Wingender et al, 2011). The formation of biofilm is seen in sewage plants,
water systems and medical devices (Donlan & Costerton, 2002; Wingender et al, 2011). In
clinical settings, biofilm formation has been observed in medical implants, dental caries,
and intravascular catheters (Donlan & Costerton, 2002; Meh & O’Toole, 2001). The
persistence of biofilm infections is enhanced by mechanisms that aid in the survival of
these bacterial communities, such as extracellular polymeric substance (EPS) and the
presence of glycocalyx which inhibits efficacy of antibiotics (Limoli et al., 2015). The EPS
secreted by bacteria surrounds the cell with a layer of protection from adverse
environments. Polysaccharides and proteins are used to enhance the structure of the
biofilm. It has been observed that the morphological structure of microorganisms in
biofilms is altered when compared to planktonic cells.
Bacterial biofilm formation is enhanced by the secreted signaling molecule,
autoinducer, and is dependent on bacterial density (Huber et al., 2002; Schauder et al.,
2001). When bacteria secrete this signaling molecule, it enables cell to cell communication
known as Quorum Sensing (QS) (Huber et al., 2003; Lerat and Moran, 2004; Waters et al.,
2008). Gene regulation increases the virulence factor of these organisms through the ability
of QS. This allows the establishment of infection to remain concealed through gene
regulation. The virulence of these microorganisms is elevated by addition of antibiotic
resistant genes, which are able to be exchanged with other microorganisms (Ramage et al.,
2002; Saga et al., 2009). Virulence of these microorganisms can be elevated by horizontal
gene transfer or incorporation of plasmids (Davin-Regli & Pagès, 2015; Saga et al., 2009;
Viveirose et al., 2007). The exchange of antibiotic genes from Klebsiella pneumoniae to
Enterobacter spp. can be observed through horizontal gene transfer.
The formation of fungal biofilm has not been studied to the same extent as bacterial
biofilm (Chandra et al., 2001). QS has also been observed in C. albicans. The ability for
11

C. albicans to form a biofilm is enhanced by filamentation, allowing growth in size rather
than cell number (Ramage et al., 2017). Sucrose enhances the attachment and virulence of
C. albicans with fibrillar.

Endospore formation
The formation of endospores enables Bacillus and Clostridium spp. to become
dormant and resistant to heat, solvents and ultraviolet light. Bacillus spp. are responsible
for food poisoning and spoilage. Heat shock proteins of Bacillus spp. spores are enhanced
by increases in temperature. (Citation?)

Mode of Treatments
Once an antibiotic is able to attack a specific area of the bacterium, it will cause a
disruption in an important function within the bacterium. There are two mechanisms by
which antibiotics (ABs) affect bacteria: bactericide or bacteriostatic (Nemeth et al., 2014).
The development of new antibiotics is taking pre-existing ABs and chemically modifying
them, thus acquiring many different ABs within a particular class (CDC, 2015). The
mechanism by which ABs work is by the production of inhibitory enzymes and the
prevention of binding.
Fluconazole and Amphotericin B are the common treatments for fungal infections.
It has been observed that C. albicans has presented resistance to both treatments (Ramage
et al., 2002).

Antimicrobial Resistance
In recent years the excessive use of antibiotics has initiated a global health concern
resulting in antibiotics resistance (CDC, 2015). The inappropriate use of antibiotics by
individuals has played a role in the acquisition of antibiotic resistance by bacteria due to
incomplete antibiotic regimen and persistence of patients’ requests for antibiotics (CDC,
2015; McDevitt et al.,2002; Saga et al., 2009). Many once commonly treated bacterial
infections have become difficult to manage due to overuse as growth promoters for fish
and livestock (CDC, 2015; Gilchrist et al., 2007). Livestock that are contaminated with
ARB can be transferred to individuals during food preparation and consumption (CDC,
12

2015; Gilchrist et al., 2007). It has been noted that the use of antibiotics in livestock should
be limited to incidents of infection within a group of livestock that are produced for
consumption.
The detection of antibiotics present in the sediment and soil can be attributed to
overflow of livestock waste and industrial waste from pharmaceutical companies (CDC,
2015; Kolpin et al., 2002; Wingerder et al., 2011). Antibiotics Resistant Bacteria (ARB)
eventually reside in environmental water reservoirs such as sewage waste, surface water,
and aquatic sediment in the vicinity of livestock and pharmaceutical companies (CDC,
2015; Kolpin et al., 2002; Wingerder et al., 2011). Significant levels of ARB are detected
in the environment higher than initially predicted (Kolpin et al., 2002; Wingerder et al.,
2011).

Figure 1: Flow chart of Antibiotic Resistance (CDC, 2015)

However, over the course of 70 years of antibiotic usage, it was observed that
certain infections were not being eliminated by the antibiotics once commonly prescribed
to treat them (Li et al.,2015). Recently, much effort has been made to produce stronger
antibiotics that can combat ARB. Vancomycin (produced in 1972) was typically used as
the final antibiotic for treatment of infections (McDevitt et al.,2002; Viveirose et al., 2007).
ARB resistance to Vancomycin is observed in several species of bacteria. The rate of
microorganisms acquiring antibiotic resistance can be observed within a year of
13

production. The amount of antibiotic production has decreased due to the acquired
resistance to whole classes of antibiotics. It can be observed in Figure 2 that the
development of antibiotics has decreased in the past 40 years (Aminov, 2010; CDC, 2015;
Saga et al., 2009).

Figure 2. Decreased development of antibiotics (CDC, 2015)

Antimicrobial Resistance Mechanisms
A variety of physical and genetic mechanisms have been linked to antibiotic
resistance in bacteria (Saga et al., 2009; Viveirose et al., 2007). Efflux pumps and
membrane permeability are physiological mechanisms that are attributed to antibiotic
resistance (Viveirose et al., 2007). Efflux pumps have been able to control the direction of
the flow of antibiotics back out of the cell (Figure 3) (Giedraitiene et al.,2011; Li et al.,
2015; Viveiros et al.,2007).
Mobile genetic elements (MGE), plasmids and horizontal gene transfer (HGT) are
genetic mechanisms that are associated with bacteria acquiring antibiotic resistant genes
(ARGs) (Davin-Regli & Pagès, 2015, Saga et al., 2009; Viveirose et al., 2007). Horizontal
gene transfer is the process whereby bacteria are able to pick up pieces of DNA or plasmids
that are around them and incorporate them into their own genome (Giedraitiene et
al.,2011).
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Figure 3. Illustration of efflux pump (Giedraitiene et al.,2011)

The Effect of Green Tea Polyphenol as a Potential Antimicrobial Agent
Selective pressures in the presence of antibiotics have forced bacteria to acquire
significant resistance, thus directing research towards alternative treatments. Camellia
sinensis, more commonly known as green tea, has many health benefits (Steinmann et al.,
2013). Green tea contains polyphenols which are composed of catechins. Catechins are
components of green tea which have demonstrated antibacterial, antifungal, antitoxin and
antiviral effects (Nakayama et al.,2015; Steinmann et al., 2013). Epigallocatechin-gallate
(EGCG) is the most abundant catechin in green tea (Du et al., 2012; Zaveri, 2006). EGCG
has a greater effect on gram-positive bacteria than gram-negative bacteria. It has been
observed that green tea products that contain high levels of carbohydrates have decreased
spoilage because of the presence of polyphenols within the product (Sakanaka et al., 2000).

Figure 4. Structure of EC, EGC, ECG and EGCG (Steinmann et al., 2013)
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The incorporation of EGCG at increasing concentrations has been shown to
decrease bacterial numbers (Sakanaka et al., 2000). The effects of Green Tea Polyphenol
(GTP) were shown to inhibit bacteria and spore formation even at elevated levels of sugar
(Sakanaka et al., 2000). The use of EGCG can have an effect on the biochemical activity
within the bacterial cell. Research has shown that when P. aeruginosa and E. coli were
exposed to EGCG, grooves can be seen within the lipid bilayer (Cui et al.,2012). EGCG is
dose and concentration dependent (Zaveri, 2006). Polyphenols have the ability to interfere
with biofilm formation and QS (Du et al.,2012; Steinmann et al.,2013). EGCG
demonstrates the ability to reduce microbial biofilm formation (Du et al.,2012; Steinmann
et al.,2013). The possible mechanisms of EGCG on bacteria are summarized in Table 1
and the possible mechanisms on fungi are listed in Table 2.

Target of EGCG on Bacteria
EGCG Target - Mode of Action

Reference

Inhibit of multi-drug resistance of P- Roccaro et al., 2004.
glycoprotein
Hydrogen Peroxide Production

Arakawa et al, 2004; Cui et al., 2012.

Binding to cell wall peptidoglycan (Gram Roccaro et al., 2004.
Positive)
Decrease efflux efficiency and blockage of Roccaro et al., 2004.
efflux pump passage: Tetracycline
Inhibit fatty-acid type II synthesis (β- Zhang & Rock, 2004.
ketoacyl-ACP reductase (FabG) and the
trans-2-enoyl-ACP reductase (FabI)) reduction of elongation
Inhibits Co-factor of enzymes:

Zhang & Rock, 2004.

- EGCG interferes with activity by binding
to the free enzyme and preventing the
binding of NADH
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- Nucleotide cofactor binding site, and
with FabG, EGCG has the additional
property of binding to the enzyme-cofactor
complex.
Cytoplasmic

enzyme

dihydrofolate Steinmann et al., 2013.

reductase
Table 1. Target of EGCG on Bacteria

Target of EGCG on Fungi
EGCG Target- Mode of Action

Reference

Reduction of fatty-acid synthesis with Zhang & Rock, 2004.
reductase and subdomains
Decreased proteasome

Evensen & Braun, 2009.

Disruption in folic acid synthesis

Navarro et al., 2006

Cytoplasmic

enzyme

dihydrofolate Steinmann et al., 2013.

reductase
Table 2. Target of EGCG on Fungi

Epigallocatechin- Gallate-Stearate
Epigallocatechin-Gallate-Stearate (EGCG-S) (Patent#20120171423) is a stable,
lipophilic form of EGCG. EGCG-S was used to determine the minimum inhibitory
concentration (MIC) to inhibit bacterial growth and biofilm formation in various sucrose
concentrations.

Figure 5. The Molecular Structure of EGCG-S (Hsu, 2012)
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Bacterial Profiling
In this study, a diverse selection of microorganisms were used to determine the
effectiveness of EGCG-S as an antimicrobial agent. Gram-positive and gram-negative
bacteria, as well as an acid-fast bacterium, a fungus, and endospores produced by Bacillus
spp. were studied in the presence of EGCG-S.
The gram-positive bacteria used are divided into two groups: bacillus and cocci.
Bacillus spp. used are Bacillus cereus (B. cereus), Bacillus megaterium (B. megaterium),
and Bacillus subtilis (B. subtilis). These three species were also used in the spore study due
to the formation of spores in hostile environments. Bacillus spp. is known to cause food
poisoning and spoilage (Drobniewski, 1993; Errington, 2003). The gram-positive cocci
bacteria used are: Enterococcus faecalis (E. faecalis), Micrococcus luteus (M. luteus),
Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis), and
Streptococcus mutans (S. mutans). Gram-positive cocci bacteria are the cause of diseases
such as boils and cellulitis (S. aureus) (Lowy, 1999). S. mutans is known caused of oral
diseases and formation of dental cavities (Xu et al., 2012).
The gram-negative bacteria used are as follows: Enterobacter aerogenes (E.
aerogenes), Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Proteus
vulgaris (P. vulgaris), Pseudomonas aeruginosa (P. aeruginosa), Pseudomonas
fluorescens (P. fluorescens), and Serratia marcescens (S. marcescens).
An acid-fast bacterium, Mycobacterium smegmatis (M. smegmatis), which has
characteristics similar to the organism responsible for tuberculosis was selected due to cell
wall composition (McDevitt et al, 2002).
Candida albicans (C. albicans) was chosen as representative fungal
microorganism. It is a unicellular yeast responsible for Candidiasis, causing cavities and
periodontitis (Ramage et al., 2002).
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Objectives of this study
These studies demonstrate the potential use of EGCG-S as an alternate therapy to excessive
antibiotic agents:
1) Profiling the inhibitory effect of EGCG-S against 17 microorganisms (eight Grampositive, seven Gram-negative, one Acid-fast, and one Fungus)
2) Profiling the effectiveness of EGCG-S on biofilm formation and pre-formed biofilm in
16 bacterial spp.
3) Evaluation of EGCG-S as antibacterial and antifungal agent
a) Pre- and Post-Application using EGCG-S
b) Application of Prototype ProtecTeaV
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Materials and Methods
1. Pre/Post-experiment Set-up
The Biosafety Level 2 (BSL-2) hood was wiped down with 10% bleach and
subjected to ultraviolet light for 20 minutes before and after experiment.

2. Media Preparation
There are five types of media used in this research: Tryptic Soy Agar (TSA),
Tryptic Soy Broth (TSB), Congo Red (CR), Potato Dextrose Agar (PDA), and Modified
Nutrient Agar (MNA). All the media were prepared according to manufacturer’s protocols.
After agar media was poured into plates, they were left under the hood to solidify overnight.
The next day, the solidified agar plates were placed back into the plastic sleeve, taped and
labeled with appropriate media type and stored into a 4˚C cold room for prospective
experiments. Only Congo Red medium was used within 24 hrs after preparation.

a. Tryptic Soy Agar Preparation
TSA from Carolina was prepared using 30 grams of TSA powder media and 1L of
deionized H2O. The medium was autoclaved for 30 minutes at 121˚C. The TSA medium
was poured into mono plates, X plates, or Y plates, (Figure 6) depending on experimental
design.

Mono plate

X- plate

Y-plate

Figure 6. Depiction of petri dishes used based on experimental design.
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b. Tryptic Soy Broth Preparation
TSB from Carolina was prepared using 30 grams of TSB powder media and 1L of
deionized H2O. Sucrose (Spectrum) containing media were prepared with a final
concentration of 0.1%, 0.5%, 1%, and 5%, respectively, in Falcon flasks and autoclaved
for 30 minutes at 121˚C and then stored at 4˚C until needed.

c. Congo Red (CR) Media Preparation
CR agar medium was prepared in two separate preparations. 37 g/L of Brain heart
infusion broth from Sigma-Aldrich, 10 g/L of Bacteriological agar from Scholar Scientific
was added to 1L of deionized water. In a seperate test tube, 0.8g/L of Congo Red indicator
was autoclaved. Different sucrose concentrations of 0.1%, 0.5%, 1% and 5% were also
prepared in sucrose containing BHI plates. All solutions were autoclaved at 121˚C for 30
minutes. Once completed, the Congo Red solution and agar were cooled down to 55˚C,
evenly mixed and poured into X-plates (Gamborg & Phillips, 1995).

d. Potato Dextrose Agar (PDA) Preparation
PDA (HIMEDIA) was prepared with 39 grams of PDA powder media in 1L of
deionized H2O, autoclaved for 30 minutes at 121˚C. Once media cooled down to 55˚C, it
was poured into sterile mono plates.

e. Modified Nutrient Agar (Spore Plates)
Nutrient Agar (NA) was adapted to prepare Modified Nutrient Agar (MNA). MNA
was prepared with 23 grams of NA media (DifcoTM) in 1L of deionized H2O and combined
with 0.06 g/L of Magnesium sulfate and 0.25 g/L of Monopotassium phosphate. The
medium was autoclaved for 30 minutes at 121˚C and allowed to cool down, then poured
into sterile X-plates (Gamborg & Phillips, 1995).

3. Culturing
a. Bacterial Cultures
Sixteen microorganisms were grown on TSA at 37˚C for 24 hours, except for M. luteus, P.
fluorescens, and S. marcescens, which were grown at 25˚C.
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Gram-positive bacteria used in this research:
Bacillus cereus (B. cereus), Bacillus megaterium (B. megaterium), Bacillus subtilis (B.
subtilis), Enterococcus faecalis (E. faecalis), Micrococcus luteus (M. luteus),
Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis), and
Streptococcus mutans (S. mutans).

Gram-negative bacteria used in this research:
Enterobacter aerogenes (E. aerogenes), Escherichia coli (E. coli), Klebsiella pneumoniae
(K. pneumoniae), Proteus vulgaris (P. vulgaris), Pseudomonas aeruginosa (P.
aeruginosa), Pseudomonas fluorescens (P. fluorescens), and Serratia marcescens (S.
marcescens).

Acid-fast bacteria used in this research:
Mycobacterium smegmatis (M. smegmatis).

After overnight growth of these bacteria, cultures were wrapped in parafilm and stored at
4˚C for future use. Bacterial purity was checked periodically by using simple or Gram stain
to confirm purity. In cases of contamination, a discontinuous steaking method was used to
isolate colonies to start a new stock. The stocks of all bacteria were prepared and stored in
-80˚C freezer. Eppendorf tubes containing 600μL of overnight cultures with 400μL of 40%
glycerol were prepared for deep freezer. (Prakash, Nimonkar, & Shouche, 2012).

b. Harvesting and Purification of Endospores
Modified Nutrient Agar (MNA) was used to grow endospore forming microorganisms, B.
cereus, B. megaterium, and B. subtilis, for 10 days at 37˚C. After 10 days, Bacillus spp.
spore production was confirmed with simple stain. Spores from Bacillus spp. were
collected in sterile DI H2O and the spores were centrifuged at 10,000rpm for 10 mins; this
process was performed three times. Spore suspension was then stored at 4˚C for future use.
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c. Candida albicans
A continuous streak of C. albicans was plated on PDA and incubated at 37˚C
overnight. A simple stain was conducted to determine purity. After overnight growth, C.
albicans was wrapped in parafilm and stored at 4˚C for future use. Continuous steak plate
was periodically prepared every two weeks to sustain C. albicans.

4. Overnight Cultures
Prior to each experiment, overnight culture of each bacterium was prepared in TSB
and grown at optimal temperature with constant shaking at 250rpm.

5. Staining Techniques
a. Simple Stain
The protocol for simple stain used in this study is described in the research lab
manual (Lee et al., 2015). Methylene blue was used for simple stains to determine purity
and morphology of all organisms in this study.

b. Gram Stain
The Gram stain was used to differentiate between Gram-positive and Gramnegative bacteria, as well as to determine the morphology of the bacteria. The Gram stain
protocol was performed as described in Microbiology Laboratory Manual (Lee et al.,
2015).

c. Schaeffer-Fulton Spore Stain
Schaeffer-Fulton spore staining (Endospore stain) method was used to stain the
spores formed by specific bacteria. The detailed protocol for Schaeffer-Fulton spore
staining was described in Laboratory manual (Lee et al., 2015). This differential staining
technique stained spores green and vegetative cells red.

d. Ziehl-Neelsen Stain
The Ziehl-Neelsen Stain (Acid-fast stain) was used to identify Mycobacterium spp.
Mycobacterium spp. retained red/pink color and non-acid-fast bacterium stained blue
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(Russell, 2001; Lee et al.,2015). The detailed protocol is described in Microbiology
laboratory manual (Lee et al., 2015).

6. Preparation of Green Tea Polyphenols
Green Tea Polyphenol EGCG-S (U.S. Patent #: 20120171423) was purchased from
Camellix LLC, Augusta, GA. EGCG-S stocks were prepared in concentrations of 10x of
100 μg/mL, 10x of 250μg/mL and 10x of 500μg/mL.

7. Growth Curve of Microorganisms
a. Standard Growth Curve of 17 Microorganisms
Overnight cultures were prepared and diluted using TSB with an Optimal Density
(OD) of 0.1 at 600nm. A 96 well plate was used to prepare 17 microorganisms and was
placed in a shaking incubator at 125 rpm at optimal temperature. Multi-plate reader,
TECAN InfiniteM200 Pro, was used to monitor the growth at 600nm every hour for 11
hours with a final reading taken at 24 hours. The growth curve was plotted using the mean
of three replicates with the Standard Deviation (SD) and plotted with OD (y-axis) vs. Time
(x-axis). The generation time was calculated using the equation: g = (log10 N1 – log10N0) /
log102 to determine the doubling time required for each organism.

b. The Effect of Sucrose on Growth of 17 Microorganisms
Seventeen microorganisms were grown in TSB with 0%, 0.1%, 0.5%, 1% and 5%
sucrose concentrations with an initial OD600 of 0.1 and were monitored for 24 hours.
Growth curve for each microorganism with each sucrose concentration was generated. The
growth was monitored as described in 6.a. The growth curves for sucrose concentrations
0%, 0.1%, 0.5%, 1%, and 5% were plotted using triplicate means with the Standard
Deviation (SD). The generation time was calculated using the equation from 6.a. to
determine doubling time for each microorganism in different sucrose concentrations.
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8. The Effect of EGCG-S on 17 Microorganisms
Overnight cultures of 17 microorganisms were used to study the effectiveness of
EGCG-S at 0% and 0.1% sucrose. Serial dilutions were carried out to obtain a countable
range between 30 and 300. The flow chart for serial dilutions are illustrated in Figure 7.

Figure 7. Serial dilution follow chart to obtain countable range of microorganisms.

Figure 8. Serial dilution flow chart to obtain countable range of EGCG-S treated
microorganisms.
After 2 and 24 hrs, samples for control and treated were diluted to 10-6 and 10-3,
respectively. 25μL of each diluted sample was plated on a Y-plate and incubated at optimal
temperature for 24 hours (Dhankhar et. Al, 2012). After incubation, the colony count was
collected from triplicates control and treated microorganisms, respectively. The percent of
inhibition was calculated for each organism to determine the effectiveness of EGCG-S.
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% 𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =

(𝐶𝐹𝑈 𝑜𝑓 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 − 𝐶𝐹𝑈 𝑜𝑓 𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)
× 100%
𝐶𝐹𝑈 𝑜𝑓 𝐶𝑜𝑛𝑡𝑟𝑜𝑙

a. The Effect of EGCG-S on the Growth of 17 Microorganisms
Overnight cultures of all microorganisms were prepared and diluted to an OD600nm
at 0.1. Samples were aliquoted into Eppendorf tubes with 100μL of sample and centrifuged
at 13,000 rpm for 1 minute. Control samples and treated samples were resuspended in 50μL
and 45μL of TSB, respectively. The addition of 5μL of 10x of 250 EGCG-S for a total
volume of 50μL in the treated sample. Triplicates were performed for each microorganism
on TSA Y-plates. Control and treated samples were diluted to 10-6 and 10-3, respectively.
Further dilution was required for certain bacteria. The plates were incubated 37˚C for 24
hrs and colonies were counted to determine colony forming unit CFU/mL.

b. The Effect of EGCG-S on growth in 0.1% Sucrose of 17 Microorganisms
using Colony Forming Unit (CFU)
The protocol from 7.a. was followed for all 17 microorganisms. Control samples
and treated samples were resuspended in 50μL and 45μL of TSB with 0.1% sucrose,
respectively. A total volume of 50μL was obtained with the addition of 5μL of 10x of 250
EGCG-S. The method was described in 7.a.

9. Effect of Green Tea Polyphenol EGCG-S on Biofilm
a. Congo Red Assay on Biofilm Formation
Overnight bacterial cultures were aliquoted into Eppendorf tubes: 50 μL, 49 μL,
47.5 μL, and 45 μL, respectively. The control samples had 50μL each. Concentrations of
1, 2.5 and 5 μg/mL of EGCG-S were added, respectively, to each Eppendorf tube, for a
total volume of 50 μL. Samples were incubated at room temperature for 24 hrs. After 24hrs,
X plates were used and each quarter of the plate was inoculated with 10 μL of control, 100,
250 and 500 μg/mL treated samples, respectively. Plates were incubated at optimal
temperature and observed at 24 and 48 hrs to evaluate biofilm formation.

Dark

precipitation indicates biofilm formation.
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b. Congo Red Assay on Biofilm Formation with Sucrose
Experiment was set up as described in 8a. Congo Red plates containing 0%. 0.1%,
0.5%, 1% and 5% sucrose were plated with 10 μL of each sample. Each quarter of the plate
contained a control, treatment with 100, 250 and 500 μg/mL respectively. Plates were
incubated at optimal temperature and observed at 24 and 48 hrs to observe biofilm
formation at the various sucrose countertractions mentioned above.

c. Congo Red Assay on Pre-Formed Biofilm
The bacterial were grown at CR plate for 48 hrs to obtain biofilm. Congo Red
plates were placed on inverted microscope to evaluate pre-formed biofilm and then treated
with EGCG-S on Staphylococcus aureus. 50 μL of 500μg/mL was added to the pre-formed
biofilm. The samples from both pre-formed biofilm and reversal treatment were viewed
and photographed using inverted and fluorescence microscopes.

10. Microscopic observation
a. Fluorescence Microscopy using BacLight™ Live and Dead Assay
Ten μL of bacterial sample was smeared onto a plain slide on a labeled slide tray.
The tray was kept in dark and 10 μL of Syto®9 dye from the LIVE/DEAD® Baclight TM
Kit was added to each slide with a cover slip placed on top. Slide tray was covered with
aluminum foil and left at room temperature for 20 minutes. Each slide was viewed under
1000X total magnification using a ZEISS fluorescence microscope.

b. Inverted Microscopy
Congo Red plates were placed on JencoTM USA inverted microscope to evaluate biofilm
formation and treatment of pre-formed biofilm. Images were taken under 40X
magnification to determine density of biofilm before and after the treatment.

11. Pre and Post Application of EGCG-S Using Rapid Agar Plate Assay (RAPA)
a. Pre-Application of EGCG-S
Twenty-five (25) uL of 10x of 250 μg/mL of EGCG-S was applied to each section
of TSA Y-plate 1 hour prior to application of the microorganism. All microorganisms were
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diluted to an OD600nm reading of 1.0 and diluted to 10-6 using sterile DI H2O. 25 μL of
diluted microorganism samples were spread onto control and treated plates, respectively.
All plates were incubated at optimal temperature overnight. CFU was obtained and percent
of inhibition was calculated.

b. Post-Application of EGCG-S
25μL of all microorganism dilutions of 10-6 from 10a. were plated on TSA Y-plates
and air dried for five minutes. 25μL of 10x of 250μg/mL of EGCG-S were applied onto
section of the Y-plate. All plates were incubated at optimal temperature overnight and CFU
was obtained, % of inhibition was calculated.

12. Evaluation of formulated tea antimicrobial product
Formulated ProtecTeaV 0 (Pro 0) and ProtecTeaV 0.1 (Pro 0.1) (Figure 9) was
provided by Dr. Hsu to be used to determine the effectiveness of these products on C.
albicans and Bacillus spp. spores. Formulations consist of ethyl alcohol (Pro 0) and ethyl
alcohol with EGCG-S (Pro 0.1) respectively.

Figure 9. ProtecTeaV
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a. Candida albicans Suspension Study
50μL of undiluted overnight culture of C. albicans was aliquoted into Eppendorf
tubes and 450μL of Pro 0 and Pro 0.1 were added, respectively. 100μL of each treatment
was plated on PDA. C. albicans was diluted to 10-4 and 100μL was plated on TSA mono
plates. Plates were incubated for at 37˚C. After 24 hrs, colonies were counted and
percentage of inhibition was determined.

b. Spore Study
Spores, harvested as described in 3.a., were diluted to 0.1 at OD600nm. 100μL of
each Bacillus spp. spores were added to an Eppendorf tubes and centrifuged at 13,000 rpm
for 60 seconds. The supernatant was removed and 100μL of Pro 0 and Pro 0.1, respectively,
was added for 30 and 60 seconds. Each treatment sample was diluted to 10-3 and 10-4 and
25μL of each dilution was added to an X-plate. After incubation at 37˚C for 24hrs, colony
count was obtained for each dilution to determine the percentage of inhibition.
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Results & Discussion
1. Characterization of 17 Microorganisms
All Microorganisms were divided into four groups: Gram-positive Bacillus and Cocci,
Gram-negative, Acid-fast Bacterium and Fungi.

a. Gram-positive Bacteria
i. Gram-positive Bacillus
Three Gram-positive Bacillus spp. were gram stained and spore stained for their
bacterial and endospore properties. B. cereus, B. megaterium, and B. subtilis were all grown
at 37˚C. Bacillus spp. can alternate between vegetative and endospore state, depending on
their surrounding environment. In the vegetative state, Bacillus spp. were stained using the
gram stain (Fig. 10 A- C). Represented by purple rods, indicating Gram-positive bacillus.
Bacillus spp. are endospore formers and can form spores in hostile environments. A spore
stain was performed to illustrate the endospores in these species (Fig. 10 A’- C’).

Bacillus cereus
A.

A’.
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Bacillus megaterium
B’.

B.

Bacillus subtilis
C’.

C.

Figure 10. Gram stain of A. B. cereus, B. B. megaterium, and C. B. subtilis at 1000x. Spore
stain of A’. B. cereus, B’. B. megaterium, and C’. B. subtilis at 1000x

ii. Gram-positive Cocci
Five Gram-positive bacteria, E. faecalis, M. luteus, S. aureus, S. epidermidis, and
S. mutans, were analyzed: All the bacteria were grown at 37˚C, except for M. luteus, which
was grown at 25˚C. A Gram stain was performed on all five bacteria and were observed to
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be purple spherical, indicating that they are all gram-positive cocci bacteria, as shown in
Fig. 11.

Enterococcus faecalis
A.

Micrococcus luteus
B.

Staphylococcus aureus
C.

Staphylococcus epidermidis
D.
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Streptococcus mutans
E.

Figure 11. A-E: Gram stain of A. E. faecalis, B. M. luteus, C. S. aureus, D. S. epidermidis,
and E. S. mutans at 1000x.

b. Gram-negative Bacteria
Seven Gram-negative bacteria were used in this study. E. aerogenes, E. coli, K.
pneumoniae, P. vulgaris, P. aeruginosa, P. fluorescens, and S. marcescens were grown at
37˚C, except for P. fluorescens and S. marcescens, which were grown at 25˚C. A Gram
stain was performed on all seven bacteria and each bacterium was observed to be pink rods,
indicating gram-negative bacillus as shown in Fig. 12.
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Enterobacter aerogenes

Escherichia coli

A.

B.

Klebsiella pneumoniae

Proteus vulgaris

C.

D.
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Pseudomonas aeruginosa

Pseudomonas fluorescens

E.

F.

Serratia marcescens
G.

Figure 12. Gram stain of A. E. aerogenes, B. E. coli, C. K. pneumoniae, D. P. vulgaris, E.
P. aeruginosa, F. P. fluorescens, and S. marcescens at 1000x.

c. Acid-fast bacterium
M. smegmatis was grown at 37˚C for this study. They have an unusual lipid layer
on the cell surface and are difficult to stain by Gram stain technique. Acid-fast stain was
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designed specifically for Mycobacterium spp. and was used for this microorganism as
shown in Fig. 13. The pink rods represent Acid-fast positive.

Mycobacterium smegmatis

Figure 13: Acid-Fast Stain of M. smegmatis at 1000x.

d. Fungi
C. albicans, an unicellular eukaryotic fungus, was grown at 25˚C and stained with
methylene blue as shown in Fig. 14. The morphology is very similar to yeast and is
spherical.

36

Candida albicans

Figure 14: Simple Stain of C. albicans at 1000x.

2. Standard Growth Curves of 17 Microorganisms
A standard growth curve was generated for each organism at its optical growth
temperature. The initial optical density (OD) of each culture was 0.1 at 600nm in a 96- well
plate containing TSB. The growth was monitored every hour for 11 hrs and a final reading
was performed at 24 hrs. Each standard growth curve exhibited a lag phase, exponential
(log) phase, and stationary phase. The generation time of each bacterium was determined
by the log phase of growth. During the exponential phase of growth for each
microorganism the generation time was calculated using the formula:
g = (log10 N1 – log10N0) / log102
This formula generates the doubling time required for each microorganism’s growth at
optimal temperature. At the end of 24 hrs, the OD was obtained to determine the density
of the cells at the end of monitoring time.

a. Gram-positive Bacteria
i. Gram-positive Bacillus
The standard growth curves for three Bacillus spp. were monitored and shown in
Fig. 15A-C. The growth curves are similar. All Bacillus spp. were observed to be entering
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exponential phase at 4 hrs. At exponential growth, the cells have constant generation time:
B. cereus was 43.56 mins, B. megaterium was 65.39 mins, and B. subtilis was 77.50 mins.
B. cereus, B. megaterium, and B. subtilis reached the stationary phase at 6, 10 and 8,
respectively. Since these microorganisms are endospore formers, the monitoring was
continued up to 24 hrs.
A.

B.

C.
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Figure 15. Standard Growth Curves of three gram-positive bacillus cultures were
performed in triplicates with the mean and standard deviation (SD) represented. The
growth curve was obtained through the turbidity study from 0 to 11 hrs. The x-axis
represents the time in hrs and the y-axis represents the absorbance at 600nm.

ii. Gram-positive Cocci
The standard growth curves for E. faecalis, M. luteus, S. aureus, S. epidermidis and
S. mutans were generated as shown in Fig. 16. E. faecalis S. aureus and S. mutans were
observed to have lag phase for about 2 hrs. M. luteus and S. epidermidis had lag phase for
3 and 4 hrs, respectively. The stationary phases of E. faecalis, M. luteus, and S. aureus
were achieved at hour 8. Both S. epidermidis and S. mutans were observed to enter
stationary phase at hour 10. The generation time for each bacterium were as follows: for
E. faecalis was 84.41 mins, M. luteus was 73.15 mins, S. aureus was 94.71 mins, S.
epidermidis was 56.87 mins, and S. mutans was 51.56 mins.

A.

B.
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C.

D.

E.

Figure 16. Standard Growth Curves of five gram-positive cocci cultures were performed
in triplicates with the mean and SD represented. The growth curve was obtained through
the turbidity study from 0 to 11 hrs and a final reading taken at 24 hrs. The x-axis represents
the time in hrs and the y-axis represents the absorbance at 600nm.
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b. Gram-negative Bacteria
The standard growth curves for E. aerogenes, E. coli, K. pneumoniae, P. vulgaris,
P. aeruginosa, P. fluorescens, and S. marcescens were generated as shown in Fig. 17.
Similar initiation of exponential phase was observed at hour 4 in E. aerogenes, P. vulgaris,
P. aeruginosa, and S. marcescens. K. pneumoniae, P. vulgaris, and P. aeruginosa reached
to the stationary phase by 6 hrs or 7 hrs. S. marcescens reached stationary phase at 8 hrs.
While E. aerogenes, E. coli and P. fluorescens stayed exponential up to 11 hrs. The final
reading for E. aerogenes, E. coli and P. fluorescens indicated that growth occurred past 11
hrs. Increased growth was observed at the final reading at 24 hrs. The generation time for
E. aerogenes was 85.91 mins, E. coli was 80.07 mins, K. pneumoniae was5 9.15 mins, P.
vulgaris was 64.26 mins, P. aeruginosa was 55.16 mins, P. fluorescens was 124.3 mins,
and S. marcescens was 73.67 mins.

A.

B.
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C.

D.

E.

F.
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G.

Figure 17. Standard Growth Curves of seven gram-negative bacillus cultures were
performed in triplicates with the mean and SD represented. The growth curve was obtained
through the turbidity study from 0 to 11 hrs and a final reading taken at 24 hrs. The x-axis
represents the time in hrs and the y-axis represents the absorbance at 600nm.
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c. Acid-fast bacterium
A Standard Growth Curve of Acid-Fast bacterium, M. smegmatis, was generated as
shown in Fig. 18. It had a long lag phase for 4 hrs and reached the stationary phase by 6
hrs. M. smegmatis had a generation time of 74.30 mins.

Figure 18. A Standard Growth Curve of Acid-Fast bacterium, M. smegmatis, was
performed in triplicates with the mean and SD represented. The growth curve was obtained
through the turbidity study from 0 to 11 hrs and a final reading taken at 24 hrs. The x-axis
represents the time in hrs and the y-axis represents the absorbance at 600nm.
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d. Candida albicans
A Standard Growth Curve of C. albicans was generated as shown in Figure 19. It
showed that the lag phase lasted for 3 hrs. Finally, reaching the stationary phase by 7 hrs.
The calculated generation time for C. albicans was 87.1 mins.

Figure 19. A Standard Growth Curve of Fungi, C. albicans, was performed in triplicates
with the mean and SD represented. The growth curve was obtained through the turbidity
study from 0 to 11 hrs and a final reading taken at 24 hrs. The x-axis represents the time in
hrs and the y-axis represents the absorbance at 600nm.

The generation times for all of these microorganisms are longer than the reported
times. This may be because growth was monitored in a 96-well plate and agitation at 125
rpm less than the regular growth at 250 rpm. In addition, a total of 100μl of culture was
used in each study. The nutrient may be a limiting factor for their growth thus many of the
organisms reached to the stationary phase earlier than expected.
Bacillus spp., Enterobacter aerogenes, Escherichia coli, and Pseudomonas
fluorescens were still in the exponential phase at hour 11. The growth was monitored for
24 hrs for these organisms. The results suggested that they were continued growth
throughout the monitoring time. The constructed growth curves of Bacillus spp. were
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similar to growth curve observed by (Lalata, 2017); this may due to the formation of
endospores.

3. The Growth of Microorganisms in Different Percentages of Sucrose
It has been reported that sugar can affect the biofilm formation (Leme et al., 2006),
thus the effect of sucrose on the growth of microorganisms was studied. Each
microorganism was grown in sucrose concentrations of 0%, 0.1%, 0.5%, 1%, and 5% and
growth curves were generated accordingly (Fig. 20-24) at optical growth temperature. The
growth in different conditions were compared with the control. Through the monitoring
process, the generation time and final cell density were summarized in Table 3 for each
bacterium.

a. Gram-positive Bacteria
i. Gram-positive Bacillus
The growth pattern of gram-positive bacillus in different sugar concentrations was
very similar to the control as shown in Fig. 20. Sucrose does not affect the length of the
log phase, but the end cell density changed. The generation time was determined in
different sucrose concentrations in each bacterium, summarized in Table 3. B. cereus at
0%, 0.1%, 0.5%, 1% and 5% have a generation time of 43.56mins, 44.52 mins, 42.08 mins,
43.53 mins, and 76.61mins, respectively. B. megaterium at 0%, 0.1%, 0.5%, 1% and 5%
have a generation time of 65.39mins, 67.49 mins, 60.97 mins, 48.66 mins, and 53.33 mins,
respectively. B. subtilis 0%,0.1%, 0.5%, 1% and 5% at 77.50 mins, 93.87 mins, 77.86 mins,
74.09 mins, and 91.83 mins, respectively. These results suggested that with increasing
amounts of sucrose concentrations the growth of Bacillus spp. was enhance compared with
the control, except B. cereus in 5% sucrose. The shortest generation in each bacterium is
different in different sucrose concentrations: for B. cereus (0.5%) was 42.08 mins, B.
megaterium (1%) was 48.66 mins, and B. subtilis (1%) was 74.09 mins. The cell density
of each Bacillus spp. was monitored until 11 hrs and evaluated at each sucrose
concentration. The results for B. cereus indicated that the cell density was higher in all
sucrose concentrations than the control. B. megaterium had the shortest generation time in
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1% sucrose, but the final cell density was higher in 0.1 and 0.5% sucrose after 11 hrs. The
cell density of B. subtilis was higher than control for 0.1%, 0.5% and 1%.

A.

B.

C.
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Figure 20. Growth Curves of three gram-positive bacillus cultures with different
sucrose concentrations were generated in triplicates with the mean and SD represented.
The growth curve was obtained through the turbidity study from 0 to 11 hrs. The x-axis
represents the time in hrs and the y-axis represents the absorbance at 600nm.

ii. Gram-positive Cocci
The growth pattern for all sugar concentrations for M. luteus, S. aureus, S.
epidermidis, and S. mutans are very similar to the control as shown in Fig.21. The
generation time was determined in different sucrose concentrations and each bacterium. E.
faecalis at 0%, 0.1%, 0.5%, 1% and 5% had generation time of 84.41 mins,77.61 mins,
52.28 mins, 57.73 mins, and 192.4 mins, respectively. M. luteus at 0%, 0.1%, 0.5%, 1%
and 5% had generation time of 73.15 mins,77.87 mins, 83.94 mins, 84.57 mins, and 48.89
mins, respectively. S. aureus at 0%, 0.1%, 0.5%, 1% and 5% had generation time of 94.71
mins, 100.3 mins, 93.55 mins, 105.9 mins, and 94.39 mins, respectively. S. epidermidis at
0%, 0.1%, 0.5%, 1% and 5% had generation time of 56.87mins, 68.69 mins, 98.87 mins,
65.04 mins, and 82.68 mins, respectively. S. mutans at 0%, 0.1%, 0.5%, 1% and 5% had
generation time of 51.56 mins, 52.71 mins, 53.84 mins, 59.21 mins, and 42.43 mins,
respectively. The results suggest that with increasing amounts of sucrose concentrations,
gram positive cocci growth was enhanced, except for S. epidermidis. The shortest
generation in each bacterium is different; for E. faecalis (0.5%) was 52.58 mins, M. luteus
(5%) was 48.89 mins, S. aureus (0.5%) was 93.55 mins, S. epidermidis (0%) was 56.87
mins, and S. mutans (5%) was 42.43 mins. At all sucrose concentrations S. mutans was
observed to have a final cell density higher than the control. S. epidermidis had a higher
cell density in sucrose concentrations of 0.1%, 0.5% and 1%. Through the turbidity study,
the final cell density of E. faecalis was highest in sucrose concentrations 0.1% and 0.5%.
S. aureus was observed most cells with 0.5% and 1% sucrose.
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A.

B.

C.

D.
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E.

Figure 21. Growth Curve of five gram-positive cocci cultures with different sucrose
concentrations were generated in triplicates with the mean and SD. The growth curve was
obtained through the turbidity study from 0 to 11 hrs and a final reading taken at 24 hrs.
The x-axis represents the time in hrs and the y-axis represents the absorbance at 600nm.

b. Gram-negative Bacteria
The growth patterns of gram-negative bacteria in different sugar concentrations are
shown in Fig. 22. The generation time was determined in different sucrose concentrations
in each bacterium. The shortest generation in each bacterium was: 71.55 mins for E.
aerogenes (5%), 48.89 mins for E. coli (0.5%), 53.46 mins for K. pneumoniae (1%), 64.26
mins for P. vulgaris (0%), 50.65 mins for P. aeruginosa, 98.46 mins for P. fluorescens
(0.1%) and 68.19 mins for S. marcescens (1%). All gram-negative bacillus showed that in
all sucrose concentrations growth was enhanced, except P. vulgaris. The generation time
was determined in different sucrose concentrations and each bacterium as summarized in
Table 3. E. aerogenes at 0%, 0.1%, 0.5%, 1% and 5% had generation time of 85.91
85.91mins, 75.66mins, 71.82mins, 64.53mins, and 71.55 mins, respectively. The
generations times calculated for E. coli at 0%, 0.1%, 0.5%, 1% and 5% were, 80.07mins,
98.07mins, 65.57mins, 103.1mins, and 89.62 mins, respectively. K. pneumoniae at 0%,
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0.1%, 0.5%, 1% and 5% had generation times of 59.15 mins, 69.39 mins, 96.08 mins, 53.46
mins, and 65.68 mins, respectively. The generation times of P. vulgaris at 0%, 0.1%, 0.5%,
1% and 5% were calculated to be 64.26 mins, 82.74 mins, 74.74 mins, 74.43 mins, and
84.09 mins, respectively. P. aeruginosa at 0%, 0.1%, 0.5%, 1% and 5% generation times
were calculated to be 55.16 mins, 63.82 mins, 54.14 mins, 50.65 mins, and 60.50 mins,
respectively. P. fluorescens grown in 0%, 0.1%, 0.5%, 1% and 5% had generation times of
124.7 mins, 98.46 mins, 109.0 mins, 138.2 mins, and 160.2 mins, respectively. S.
marcescens at 0%, 0.1%, 0.5%, 1% and 5% had generation times of 73.67 mins, 74.49
mins, 68.74 mins, 68.19 mins, and 90.53 mins, respectively. The shortest generation time
in each bacterium was different; E. aerogenes (5%) was 71.55 mins; E. coli (0.5%) was
48.89 mins; K. pneumoniae (1%) was 53.46 mins; P. vulgaris (0%) was 64.26 mins; P.
aeruginosa (1%) was 50.65 mins; P. fluorescens (0.1%) was 98.46 mins; and S.
marcescens (1%) was 68.19 mins. Final cell densities of both P. vulgaris and P. aeruginosa
were higher at sucrose concentration of 1%, which correlates with shortest duration of
growth of P. aeruginosa. E. coli and S. marcescens both had higher cell density at 0.1%,
0.5% and 1% sucrose concentrations. K. pneumoniae 11 hrs cell density reading did not
increase with any sucrose concentration. While E. aerogenes had an increase in cell density
at 0.1% and 0.5%, P. fluorescens had an increase at 0.5%. and 1%.
A.

B.
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C.

D.

E.

F.

52

G.

Figure 22. Growth Curves of seven gram-negative bacillus cultures with different sucrose
concentrations were generated in triplicates with the mean and SD represented. The growth
curve was obtained through the turbidity study from 0 to 11 hrs and a final reading taken
at 24 hrs. The x-axis represents the time in hrs and the y-axis represents the absorbance at
600nm.

c. Acid-fast bacterium
The growth pattern of gram negative bacteria in different sugar concentrations are
shown in Figure 23. The growth pattern of M. smegmatis decreased with increasing
amounts of sucrose concentrations as shown in Table 3. The shortest generation time for
M. smegmatis was (0%) 74.30 mins. M. smegmatis at 0%, 0.1%, 0.5%, 1% and 5% had a
generation time of 74.30 mins, 97.92 mins, 92.55 mins, 82.47 mins, and 89.28 mins,
respectively. At 0.1% and 0.5%, the final density was higher compared to the control after
11 hrs.
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Figure 23. A Growth Curve of Acid-fast positive bacterium, M. smegmatis, with different
sucrose concentrations were generated in triplicates with the mean and SD represented.
The growth curve was obtained through the turbidity study from 0 to 11 hrs and a final
reading taken at 24 hrs. The x-axis represents the time in hrs and the y-axis represents the
absorbance at 600nm.

d. Candida albicans
The growth of C. albicans was monitored in sucrose concentrations shown in
Figure 24. The growth pattern of C. albicans increased with amounts of sucrose
concentrations. The shortest generation time for C. albicans was (0.5%) 86.14 mins
observed in bold and highlighted green in Table 3. C. albicans at 0%, 0.1%, 0.5%, 1% and
5% had generation times of 87.1 mins, 100.2 mins, 86.14 mins, 87.78 mins, and 91.07
mins, respectively. The final cell density of C. albicans did not increase compared to
control.
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Figure 24. A Growth Curve of Fungi, C. albicans, with different sucrose concentrations
were generated in triplicates with the mean and SD represented. The growth curve was
obtained through the turbidity study from 0 to 11 hrs. The x-axis represents the time in hrs
and the y-axis represents the absorbance at 600nm.
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Bacterial Name

Generation time in Sucrose Concentrations
Gram-Positive Bacillus

B. cereus

0%

0.1%

0.5%

1%

5%

43.56

44.52

42.08

43.52

76.61

+

+

+

+

67.49

60.97

48.66

53.33

+

+

-

-

93.87

77.86

74.09

91.83

+

+

+

-

Cell Density
B. megaterium

65.39

Cell Density
B. subtilis

77.50

Cell Density

Gram-Positive Cocci
E. faecalis

84.41

Cell Density
M. luteus

73.15

Cell Density
S. aureus

94.71

Cell Density
S. epidermidis

56.87

Cell Density
S. mutans

51.56

Cell Density

77.61

52.58

57.73

192.4

+

+

-

-

77.87

83.94

84.57

48.89

-

-

-

+

100.3

93.55

105.9

94.39

-

+

+

+

68.69

68.87

65.04

82.68

+

+

+

-

52.71

53.84

59.21

42.43

+

+

+

+

Gram-Negative Bacillus
E. aerogenes

85.91

Cell Density
E. coli

80.07

Cell Density
K. pneumoniae

59.15

Cell Density
P. vulgaris
Cell Density

64.26

75.66

71.82

64.53

71.55

+

+

-

-

98.07

65.57

103.1

89.62

+

+

+

-

69.39

96.08

53.46

65.68

-

-

-

-

82.74

74.74

74.43

84.09

-

-

+
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P. aeruginosa

55.16

Cell Density
P. fluorescens

124.7

Cell Density
S. marcescens

73.67

Cell Density

63.82

54.14

50.65

60.50

-

-

+

-

98.46

109.0

138.2

160.2

-

+

+

-

74.49

68.74

68.19

90.53

+

+

+

-

Acid-fast bacterium
M. smegmatis

74.30

Cell Density

97.92

92.55

82.47

89.28

+

+

-

-

100.2

86.14

87.78

91.07

-

-

-

-

Fungi
C. albicans

87.1

Cell Density

Table 3. The generation times of 16 microorganisms are shown for control and bacterium
grown in 0.1%, 0.5%, 1%, and 5% of sucrose, calculated in minutes.

In summary, the generations times varied depending on organisms as well as
sucrose concentrations. The generation times shortened in most microorganisms in the
presence of sucrose, except for S. epidermidis, P. vulgaris, and M. smegmatis. The growth
of these three bacterial spp. was not enhanced in any sucrose concentration.

4. The Effect of EGCG-S on All Microorganisms
To determine the effect of EGCG-S on all microorganisms, CFU Assay was used.
The cultures were treated with 250μg/mL EGCG-S for 2 hrs and 24 hrs, using serial
dilution and were plated on TSA Y-plates in triplicate. The colonies were counted 24 hrs
later after incubation and the percentage of inhibition was calculated for each
microorganism. Sucrose (0.1%) was also used to study the effect of sugar on EGCG-S
efficacy as an antimicrobial agent.
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a. Gram-positive Bacteria
i. Gram-positive Bacillus
The effects of EGCG-S (250μg/mL) on gram positive endospore formers are shown
in Fig. 25. Bacillus spp. at 2 hours treatment, all had inhibition up to ~96 to 97%. At 24
hrs, the percentage of inhibition reached 99%. In the presence of 0.1% sucrose, for 2 hr.
treatment, the percentage of inhibition changed compared to the controls: 87% for B.
cereus, 98% for B. megaterium, and 91% for B. subtilis. After 24-hour treatment, the
inhibition reached near 100%. All Bacillus spp. were very sensitive to EGCG-S treatment
with 250μg/mL for both 2 hours and 24 hours treatment. The results indicated that EGCGS can effectively inhibit the growth of Bacillus spp. In the presence of 0.1% sucrose at 2
hrs, the % of inhibition reduced but at 24 hours, the inhibition was nearly complete. This
suggested that sucrose concertation does impact the inhibition of Bacillus spp.; prolong
exposure to EGCG-S is needed to reach compete inhibition.
A.

B.
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C.

Figure 25. The Percent of Inhibition of three Bacillus spp. at sucrose concentrations of 0%
and 0.1% for 2 and 24 hr treatment with 250μg/ml of EGCG-S.

ii. Gram-positive Cocci
All Gram-positive coccus spp. were susceptible to the EGCG-S treatment with
250μg/mL within 2 hrs and 24 hrs as shown in Figure 26. For 2 hrs of treatment, the % of
inhibition ranged from 92 to 99%, and for 24 hours of treatment, the % of inhibition all
reached 99% except S. aureus, which is 93.9%. In the presence of 0.1% sucrose, 2 hrs
treatment, the % of inhibition was reduced in all the bacteria except E. faecalis. M. luteus
had the lowest percent of inhibition at 69.2%; S. aureus at 77.1%. Growth in 0.1% sucrose
had a decreased inhibition for most cocci spp. at 2 hrs. This indicated that sucrose is able
to enhance the growth and hinder the activity of EGCG-S on these bacteria and may require
more than 2 hrs treatment time. After treatment for 24 hrs in 0.1% sucrose, all coccus spp.
had inhibition between 95.43 to 99.96%.
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A.

B.

C.

D.

60

E.

Figure 26. The Percent of Inhibition of five gram-positive cocci bacteria at sucrose
concentrations of 0% and 0.1% for 2 and 24 hrs treatment with 250μg/ml of EGCG-S.

b. Gram-negative Bacteria
The effects of treatment of EGCG-S on Gram-negative bacteria are shown in Figure
27. Two hr treatment with 250μg/ml of EGCG-S for all gram-negative bacteria, except K.
pneumoniae, was able to inhibit growth between 92.1 to 99.96%. K. pneumoniae was
inhibited by 71.93%. After 24 hr. treatment, all organisms were inhibited from 99.22 to
99.96%. In the presence of 0.1% sucrose, Gram-negative bacteria inhibition with 250μg/ml
of EGCG-S had decreased to 81.98 to 99.42%. Twenty-four-hour treatment was able to
inhibit bacterial growth from 97.10 to 99.99%.
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A.

B.

C.

D.

62

E.

F.

G.

Figure 27. The Percent of Inhibition of seven gram-negative bacteria are shown for sucrose
concentrations 0% and 0.1% for 2 and 24 hrs treatment with 250μg/ml of EGCG-S.
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c. Acid-fast Bacterium
The results of treatment of M. smegmatis with 250μg/mL of EGCG-S is shown in
Fig. 28. It indicated 2 hr treatment of M. smegmatis in 0% sucrose and 0.1% sucrose was
able to inhibit 78.84 and 66.44% of cell growth, respectively. Twenty-four-hour treatment
for both concentrations of sucrose had inhibition of 99.2%.

Figure 28. The Percent of Inhibition of M. smegmatis at sucrose concentrations of 0% and
0.1% for 2 and 24 hrs treatment with 250μg/ml of EGCG-S.

d. Candida albicans
C. albicans was vulnerable to the treatment with EGCG-S (Fig. 29) at 2 hrs for both
control and 0.1% sucrose, with 89.18% and 90.65% inhibition, respectively. Control
treatment was inhibited to 97.55% after 24 hrs. Inhibition of C. albicans after 24 hrs with
the addition of 0.1% sucrose had 90.41% of inhibition. This indicated that sucrose reduced
the activity of EGCG-S in treated C. albicans.
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Figure 29. The Percent of Inhibition of C. albicans at sucrose concentrations of 0% and
0.1% for 2 and 24 hrs treatment with 250μg/ml of EGCG-S.

Inhibition of most microorganisms were observed within 2 hrs treatment with
250μg/ml of EGCG-S at no sucrose condition. The minimum inhibitory concentration
(MIC) of EGCG-S for all these organisms is 250μg/ml except for K. pneumoniae and M.
smegmatis. These two organisms require longer time (24 hours) to reach the MIC. A
decrease in inhibition at 0.1% sucrose was observed in most organisms. This indicates that
sucrose has an impact on the effectiveness of EGCG-S.
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Bacterial name

Percent of Inhibition in Sucrose Concentration
Gram-Positive Bacillus

Sucrose

0% Sucrose

0.1% Sucrose

Time

2 hours

24 hours

2 hours

24 hours

B. cereus

96.58

99.86

87.07

99.90

B. megaterium

96.67

99.89

98.46

99.67

B. subtilis

95.57

98.43

90.77

98.91

Gram-Positive Cocci
E. faecalis

92.05

99.73

98.99

95.43

M. luteus

94.09

99.94

69.29

99.96

S. aureus

93.80

93.95

77.18

98.21

S. epidermidis

99.97

99.34

96.39

98.03

S. mutans

99.04

99.76

97.45

97.76

Gram-Negative Bacillus
E. aerogenes

92.91

99.81

90.92

97.10

E. coli

92.10

98.95

99.42

99.48

K. pneumoniae

71.93

99.33

95.12

98.68

P. vulgaris

99.60

99.83

94.94

99.28

P. aeruginosa

99.96

99.96

93.34

99.99

P. fluorescens

99.25

99.78

81.98

88.24

S. marcescens

95.03

99.22

98.59

99.46

66.44

99.23

90.65

90.41

Acid-fast Bacterium
M. smegmatis

78.84

99.25
Fungi

C. albicans

89.18

97.55

Table 4. Summary of Percent Inhibition of 17 microorganisms grown in 0 and 0.1% sucrose
treated with 250μg/ml EGCG-S for 2 and 24 hrs.
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e. Live/Dead Assay
LIVE/DEAD® BaclightTM Assay was preformed to differentiate the viability of
live cells (green) from dead cells (red). Overnight cultures were stained with LIVE/DEAD
dye and viewed under 1000X using Ziess fluorescence microscope (Fig. 30-32). Bacteria
treated with 250μg/ml of EGCG-S for 24 hrs were stained red, indicating that all treated
samples were dead.

a. Gram-positive Bacteria
i. Gram-positive Bacillus
Bacteria
Name

Control

Treated with 250μg/mL of
EGCG-S

B.
cereus

B.
megaterium
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B.
subtilis

Figure 30. Fluorescent microscopy of five gram-positive bacillus bacteria at 1000x.

ii. Gram-positive Cocci
Bacteria
Name

Control

Treated with 250μg/mL of
EGCG-S

E.
faecalis

M.
luteus

68

S. aureus

S.
epidermidis

S.
mutans

Figure 31. Fluorescent microscopy of five gram-positive cocci bacteria at 1000x.
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b. Gram-negative Bacteria
Bacteria

Control

Name

Treated with 250μg/mL of
EGCG-S

E.
aerogenes

K.
pneumoniae

Figure 32. Fluorescent microscopy of two gram-negative bacteria at 1000x.

The Live/Dead Assay demonstrates that gram-positive and gram-negative bacteria
were viable before treatment. Treatment with 250μg/ml of EGCG-S was able to kill all the
bacteria used in this study within 24 hrs.

6. Effect of Green Tea Polyphenol EGCG-S on Bacterial Biofilm
Brain heart infusion agar with different sucrose concentrations at 0%, 0.1%, 0.5%,
1%, and 5% with Congo Red was used for this experiment. Congo red containing media
was used to detect the presence of biofilm. Each organism was treated for 24 hrs in an
Eppendorf tube with EGCG-S concentrations of 100μg/mL, 250μg/mL, and 500μg/mL,
respectively. Untreated cultures were used as control for each condition. After treatment,
10μl of each sample was plated onto Congo red plates with various sugar concentrations
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and incubated 37˚C for 24 hrs and 48 hrs for observation. Qualitative analysis was used to
determine the presence of biofilm formation. The level of Biofilm formation was assigned
a range (Fig. 33B). The possible outcomes: No growth, growth with no biofilm production,
growth with biofilm production as shown in Fig. 34.

A.

B.

Figure 33. Congo Red Assay Set up (A) and Biofilm Formation Guide (B)

Growth No biofilm

No Growth/No Biofilm

Severely inhibited +/-

Biofilm +

Biofilm ++

Biofilm +++

Figure 34. Congo Red Assay Results. Visible outcome results for Congo Red Assay.
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A. Congo Red Assay on Biofilm Formation
a. Gram-positive Bacteria
i. Gram-positive Bacillus
All Bacillus spp. at all sucrose concentrations were able to produce biofilm
after 24 hrs. At 24 hrs, B. cereus had formed biofilm in samples treated with 100μg/mL
and 250μg/mL EGCG-S. With 500μg/mL EGCG-S was able to inhibit growth and biofilm
formation at 24 hrs. Biofilm formation was observed at 48 hrs for B. cereus at all
conditions. Biofilm formation for B. megaterium and B. subtilis was observed at all sucrose
concentrations and all concentrations of EGCG-S at 24 and 48 hrs.

Time

Control

0.1% Sucrose

1% Sucrose

5% Sucrose

(hrs)
Bacillus cereus
24
hrs

48
hrs

72

Bacillus megaterium
24
hrs

48
hrs

Bacillus subtilis
24
hrs

73

48
hrs

Figure 35. Biofilm formation of three gram-positive bacillus cultures on Congo Red Assay
with Sucrose

ii. Gram-positive Cocci
Biofilm formation was observed at all sucrose concentrations, except at 0% with
500μg/mL EGCG-S within 24 hrs. Biofilm formed at all sucrose concentrations and all
EGCG-S concentrations by 48hrs. Both M. luteus and S. mutans, were able to inhibit
biofilm formation at all sucrose concentrations treated with 500μg/mL EGCG-S at 24 and
48hrs. Observation of S. aureus 24 hrs had no biofilm formation at 500μg/mL EGCG-S at
all sucrose concentrations. After 48 hrs, biofilm formation was observed at 1% and 5%
sucrose with 500μg/mL EGCG-S. S. epidermidis treated with 500μg/mL EGCG-S was able
to inhibit biofilm formation at 0%, 0.1%, and 5% sucrose concentrations at 24 and 48 hrs.
Slight biofilm formation was observed at 24 and 48 hrs with 500μg/mL EGCG-S at 1%
sucrose.
Time

Control

0.1% Sucrose

1% Sucrose

5% Sucrose

(hrs)
Enterococcus faecalis
24
hrs

74

48
hrs

Micrococcus luteus
24
hrs

48
hrs

75

Staphylococcus aureus
24
hrs

48
hrs

Staphylococcus epidermidis
24
hrs

76

48
hrs

Streptococcus mutans
24
hrs

48
hrs

Figure 36. Biofilm formation of five gram-positive coccus cultures and M. smegmatis on
Congo Red Assay with Sucrose
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b. Gram-negative Bacteria
After 24 hrs, E. aerogenes treated with at 100μg/mL and 250μg/mL EGCG-S had
formed biofilm at all sucrose concentrations. Concentration of 500μg/mL EGCG-S was
able to inhibit biofilm formation after 24 hrs at all sucrose concentrations. E. coli biofilm
formation was inhibited with 500μg/mL EGCG-S at both 24 and 48 hours at all sucrose
concentrations. K. pneumoniae formed biofilm at all sucrose concentrations and all EGCGS concentrations. P. vulgaris treated with 500μg/mL EGCG-S at sucrose concentrations of
0%, 0.1%, and 1% did not form biofilm at 24 and 48hrs. At 5% sucrose with 500μg/mL
EGCG-S P. vulgaris was able to form biofilm at 24 and 48 hrs. Results for P. aeruginosa
and P. fluorescens were the same, where biofilm formation was inhibited with 500μg/mL
EGCG-S at 24 and 48 hrs at all sucrose concentrations. S. marcescens biofilm formation
was inhibited at all sucrose concentrations with 500μg/mL EGCG-S at 24 and 48 hrs,
except at 5% sucrose with 500μg/mL EGCG-S after 48 hrs biofilm formation was
observed.
Time

Control

0.1% Sucrose

1% Sucrose

5% Sucrose

(hrs)
Enterobacter aerogenes
24
hrs

48
hrs

78

Escherichia coli
24
hrs

48
hrs

Klebsiella pneumoniae
24
hrs

79

48
hrs

Proteus vulgaris
24
hrs

48
hrs

Pseudomonas aeruginosa

80

24
hrs

48
hrs

Pseudomonas fluorescens
24
hrs

48
hrs

81

Serratia marcescens
24
hrs

48
hrs

Figure 37. Biofilm formation of seven gram-negative bacillus cultures on Congo Red
Assay with Sucrose

c. Acid-fast Bacterium
Biofilm formation at all sucrose concentrations with EGCG-S at 100μg/mL and
250μg/mL was observed within 24 hrs. EGCG-S at 500μg/mL was able to inhibit biofilm
formation at all sucrose concentrations at 24 and 48 hrs.
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Time

Control

0.1% Sucrose

1% Sucrose

5% Sucrose

(hrs)
Mycobacterium smegmatis
24
hrs

48
hrs

Figure 38. Biofilm formation of M. smegmatis on Congo Red Assay with Sucrose

Most of the bacteria evaluated formed biofilm as early as 24 hrs and by 48 hrs all
bacterial spp. had formed biofilm in all the sucrose concentrations. For some gram-positive
bacteria, B. megaterium, B. subtilis and S. mutans, biofilm was not obvious at 24 hrs at
sucrose concentrations of 0% and 0.1%. For 1% and 5% sucrose, the biofilm formation
was significant. For gram negative bacteria similar results were observed in E. aerogenes
and K. pneumoniae. For P. vulgaris, 0% of sucrose the biofilm was not obvious but at 0.1%
sucrose the biofilm was clearly observed. For P. fluorescens no biofilm formation was
observed in all sucrose concentrations. Different concentrations of EGCG-S were used to
study the effect on biofilm formation. Concentrations of 100 and 250μg/mL were not able
to inhibit biofilm formation in all the microorganisms tested at all sucrose concentrations.
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The results indicated that EGCG-S at 500μg/ml was able to inhibit growth and biofilm
formation in most bacteria. For B. cereus, B. subtilis, and P. vulgaris 24 hrs there was no
notable biofilm formation observed but after 48 hrs the biofilm was observed. For B.
megaterium, biofilm was observed at both 24 and 48 hrs. For E. faecalis and K.
pneumoniae, 500ug/ml of EGCG-S was not able to inhibit biofilm formation. These
organisms may require a higher concentration of EGCG-S to inhibit or decrease biofilm
formation. It is clearly indicated that sucrose concentration affects biofilm formation by
enhancing and reducing the duration of the formation of biofilm. The results suggested that
500μg/mL can inhibit most biofilm formation and possibly the minimum inhibitory
concentration (MIC). Further experiments should be carried out to determine the MIC for
some bacteria for which the results were not conclusive.

B. Congo Red Assay on Pre-Formed Biofilm
Biofilm formation was observed for controls of S. aureus grown on Congo Red
plates containing 5% sucrose (Fig. 39A-C) for 24 hrs, (Fig 39A). To demonstrate the
quantity and viability of S. aureus biofilm, images were obtained using inverted and
fluorescence microscopy (Fig. 39B and C, respectively). Because the biofilm was
extremely dense, an inverted microscope was used to view the plate. Live/Dead Assay
indicated that there were viable bacteria and biofilm in the untreated cultures as shown in
in Fig. 39C. Once biofilm formation was established, the plates were utilized to determine
the effectiveness of EGCG-S in treating pre-formed biofilm. EGCG-S (50μL of 500μg/mL)
was added to the center of the pre-formed biofilm and treated for 24 hrs. Inverted and
fluorescence microscopy were utilized to compare results to the control. Results indicated
that the treatment of S. aureus using 50μL of 500μg/mL of EGCG-S was able to revert the
black agar to red (Fig. 39B’) and indicated by yellow arrow in Fig. 39A’. Examination
using the Live/Dead Assay demonstrates that 50μL of 500μg/mL of EGCG-S was able to
kill S. aureus that formed biofilm. (Fig. 39.C’). The results suggested that EGCG-S at
500μg/mL was able to kill the biofilm formed cells. This result is promising and further
study should be carried out to evaluate other biofilm forming bacteria.

84

S. aureus untreated in 5% sucrose-100x

S. aureus treated with 500μg/mL of
EGCG-S in 5% sucrose - 250x
A’.

A.

B.

B’.

C.

C’.
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Figure 39. Control and Treated Biofilm formation of S. aureus on Congo Red with 5%
sucrose observed using Interested and Fluorescence microscopy. A-C represent controls of
S. aureus grown on Congo Red plate containing 5% sucrose, inverted microscopy, and
fluorescence microscopy, respectively. A’-C’ represents the treatment of S. aureus with
500ug/ml EGCG-S, using the same methods, of controls, to evaluate treatment.

8. Pre and Post Application of EGCG-S Using Rapid Agar Plate Assay (RAPA)
The effectiveness of 250μg/mL of EGCG-S was evaluated on pre- and postapplication using RAPA.

a. Gram-positive Bacteria
i. Gram-positive Bacillus
All gram-positive bacillus spp. were used to demonstrate the inhibitory effects of
250μg/mL of EGCG-S with pre- and post-application as shown in Figure 40. Preapplication had a higher inhibition percentage compared to post-application of three
Bacillus spp. Pre-Application of EGCG-S was able to inhibit all Bacillus spp. from 64.92
to 74.57%. The inhibition of growth of three Bacillus spp. with post-application of EGCGS was between 36.43 to 68.53%.
A.

B.
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C.

Figure 40. Percent of Inhibition of three gram-positive bacillus cultures using Pre- and
Post-Application of EGCG-S.

ii. Gram-positive Cocci
Figure 41 represents the pre- and post-application of gram-positive cocci spp. with
EGCG-S. Post-application of EGCG-S had an increased inhibition for E. faecalis and S.
epidermidis at 42.28% and 39.80%, respectively. Inhibition for M. luteus, S. aureus, and
S. mutans was increased with pre-application 57.92%, 61.71%, and 91.73%, respectively.
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A.

B.

C.

D.

88

E.

Figure 41. Percent of Inhibition of five gram-positive coccus cultures using Pre- and PostApplication of EGCG-S.

b. Gram-negative Bacteria
Pre- and post-application of EGCG-S on gram-negative bacteria was illustrated in
Fig. 42. This indicated that post-application of EGCG-S was effective for most gramnegative bacteria, except for P. fluorescens. Pre-application inhibited growth of P.
fluorescens 59.11% compared to pre-application with 43.70%. Post-application was able
to inhibit growth of E. aerogenes, E. coli, K. pneumoniae, P. vulgaris, P. aeruginosa, and
S. marcescens by 38.06, 58.04, 20.19, 25.91, 39.69, and 53.84%, respectively.
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A.

B.

C.

D.

90

E.

F.

G.

Figure 42. Percent of Inhibition of seven gram-negative bacillus cultures using Pre- and
Post-Application of EGCG-S

c. Acid-fast Bacterium
The results of pre- and post-application of EGCG-S on M. smegmatis is shown in
Fig. 43. Post-application of EGCG-S with M. smegmatis was inhibited by 37.65%
compared to 27.60% for pre-application.
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Figure 43. Percent of Inhibition of M. smegmatis using Pre- and Post-Application of
EGCG-S.

d. Candida albicans
C. albicans sensitive to EGCG- with both pre- and post- application (Fig. 44). The
inhibition was over 99.6% inhibition.

Figure 44. Percent of Inhibition of C. albicans using Pre- and Post-Application of EGCGS.
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Bacterial Name

Pre-Application

Post-Application

Gram-positive Bacillus
B. cereus

74.57

36.43

B. megaterium

64.92

45.31

B. subtilis

69.24

6853

Gram-positive Cocci
E. faecalis

23.72

42.28

M. luteus

57.92

51.06

S. aureus

61.71

60.93

S. epidermidis

24.47

39.80

S. mutans

91.73

70.29

Gram-negative Bacillus
E. aerogenes

23.75

38.06

E. coli

30.05

58.04

K. pneumoniae

15.10

20.19

P. vulgaris

6.32

25.91

P. aeruginosa

30.61

39.69

P. fluorescens

59.11

45.70

S. marcescens

28.20

53.84

Acid-fast bacterium
M. smegmatis

27.60

37.65

Fungi
C. albicans

99.68

99.72

Table 5. Summary of percent of inhibition pre and post-application using EGCG-S.

In summary, C. albicans growth for pre- and post-application indicated that
inhibition with 250μg/mL of EGCG-S was sufficient to hinder growth. Most of the bacteria
were observed to have lower inhibition for pre- and post-application with 250μg/mL of
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EGCG-S. EGCG-S at 500μg/mL may be required to inhibit growth for pre- and postapplications.

9. Evaluation of the effectiveness of formulated tea as antimicrobial product
These studies used formulations of ProtecTea V 0 and ProtecTea V 0.1 to evaluate
their inhibitory effect on C. albicans and spores of Bacillus spp. ProtecTea V 0 (Pro 0) is
the formulated product without tea, and ProtecTea V 0.1 (Pro 0.1) is the formulated product
with both EGCG-S and palmitoyl-EGCG (p-EGCG).

a. Candida albicans Suspension Study
The Suspension Study demonstrated the effectiveness of Pro 0 and Pro 0.1 on C.
albicans within 60 seconds (Fig. 45). Treatments with Pro 0 and Pro 0.1 were able to inhibit
growth by 78.11 and 97.46%, respectively. The addiction of EGCG-S enhances the
effectiveness.

Figure 45. Percent of Inhibition of Suspension Study with C. albicans.
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ProtecTea V 0

ProtecTea V 0.1

Control

Figure 46. C. albicans treated with ProtecTea V 0 and ProtecTea V 0.1.

Table 6. Summary of Percent Inhibition of Suspension Study with C. albicans.

b. Spore Study
To evaluate if the formulated tea product works on the spores, three different
endospore formers, B. cereus, B. megaterium and B. subtilis, were used. They were treated
with Pro 0 and Pro 0.1 for 30 seconds and 1 minute, respectively, and CFU was determined
as shown in Figure 50. Within 30 seconds of treatment, inhibition of 12.5 to 41.67% was
observed in Pro 0 treated samples. The growth of Bacillus spp. using Pro 0 was inhibited
64.94 to 79.16 % after 60 seconds. Growth of B. cereus, B. megaterium and B. subtilis was
inhibited 86.79, 91.11 and 90.58%, respectively, within 30 seconds treatment with Pro 0.1.
While all Bacillus spp. were inhibited from 95.97 to 99.4% with Pro 0.1 for 60 seconds.
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Figure 47. The percent of inhibition by CFU of Bacillus spp. treated with ProtecTea V 0
and ProtecTea V 0.1 for 30 and 60 seconds.

Table 7. Summary of Percent Inhibition with ProtecTea V 0 and ProtecTeaV 0.1 on
Bacillus spp. for 30 and 60 seconds.

ProtecTeaV 0.1 is an effective compound for inhibition of C. albicans and spores
from Bacillus spp. with 60 seconds treatment.
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Conclusion

The study of green tea polyphenol EGCG-S was used to determine the effectiveness
an antimicrobial against bacterial growth, biofilm formation, endospores, and fungi. The
use of carbohydrate source, sucrose, was able to enhance bacterial growth and biofilm
formation of most bacteria. The minimum inhibitory concentration (MIC) of most bacterial
growth was 250μg/ml within 2 hour treatment inhibition was observed between 92 to
99.7% for gram-positive and 92.1 to 92.1 to 99.96 % for gram-negative bacteria, except
for K. pneumoniae and M. smegmatis. These two organisms require longer treatment times
or the MIC may require higher EGCG-S concentration. A decrease in inhibition at 0.1%
sucrose was observed in most organism. This indicates that sucrose has an effect on the
effectiveness of EGCG-S. From this study the use of Live/Dead Assay also determined that
treatment with 250μg/ml of EGCG-S was able to kill the organisms studied. Different
concentrations of EGCG-S were used to study their effect on biofilm formation using
Congo Red Assay. At 24 hrs, biofilm for most bacteria was observed, except for B.
megaterium, B. subtilis and S. mutans. After 48 hrs all bacteria were observed to produce
biofilm at all sucrose concentrations. Biofilm was not inhibited with EGCG-S at 100 and
250μg/mL. Results using 500ug/ml of EGCG-S was able to inhibit growth of most bacteria,
except for E. faecalis and K. pneumoniae, did not inhibit biofilm formation. MIC for these
organisms need to be further evaluated. Preformed biofilm of S. aureus indicated that
treatment with 500μg/mL of EGCG-S was able to kill the biofilm formed cells. Pre- and
post-application with EGCG-S at 250μg/mL had low inhibition percentages for all bacteria.
Pre- and post-application of C. albicans had over 99.6% inhibition. Pre- and Postapplication of 250μg/mL of EGCG-S with 0.1% sucrose had decrease inhibition for all
bacteria.Pre- and post-application with at 0% and 0.1% sucrose EGCG-S at 500μg/mL
may be able to inhibit bacterial growth. Compound ProtecTeaV 0.1 was effective on C.
albicans and endospores of Bacillus spp. within 60 seconds. EGCG-S was observed to be
a promising antimicrobial agent.
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Future Study
1. Determine CFU of EGCG-S with sucrose concentrations of 0.5%, 1% and 5% on
all microorganisms
2. RAPA will be carried out with higher concentrations of EGCG-S
3. Determine the effectiveness of ProtecTeaV on all bacteria
4.

Molecular study to determine the mode of action of EGCG-S on different bacteria
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